Business Development, Oncology and Hematology

Cambridge, England
Joined June 2012
Such an important, often overlooked, factor in due diligence and projects being competitive!
"CMC: A ‘Secret Sauce’ of Biotech Success" - new blog post from Arthur Tzianabos, CEO of Lifordi, on some good CMC learnings, along with a fun personal journey twist. This "boring" part of biotech is critically important! lifescivc.com/2025/12/cmc-a-…
1
97
My 13 year old Daughter died from #BrainCancer 4,679 days ago. 💔 I would LOVE to see my Ashley’s name 4,679 times in comments for all the days she’s been missing. When you lose a Child, the most beautiful word you can hear is their name. ❤️ A Repost & Follow would mean the world to us to keep our Ashley’s story alive. 💜 𝒜𝓈𝒽𝓁𝑒𝓎 💜
14,757
13,263
996
110,390
3,189,581
1/ A 🧵 on UK stockmarket - Today we announced a capital raise at a significant premium to the share price and an intention to delist from the London AIM market. Firstly, I am obviously sorry for the loss of liquidity/tax benefits that some retail investors will lose. That said, the total package is unquestionably… $etx
Just announced: We've raised £28.9m and are planning to delist from London’s #AIM. Proceeds from the fundraise will enable continued progression of our #RNAi assets towards the clinic and accelerated development of our #AI approaches! Find out more: londonstockexchange.com/news… $ETX #ETX #biotech
17
131
64
220
220,373
Great moment for Redx Pharma last night to see the unveiling of the first new plaque on Alderley Park's Wall of Discovery for a few years! Celebrating the approval of pirtobrutinib and the work of Nicolas E.S. Guisot, Andrew Thomason, Helen McKeever, Rich…lnkd.in/eknFXGsW
1
179
Duncan Young retweeted
We're excited to be attending The Resistant Tumor Microenvironment, Keystone Symposia next week, where Dr. Daniel Wilcock & Dr. Caroline Philips will be presenting additional preclinical efficacy data on lead fibrosis asset, RXC007, and our DDR1/2 discovery programme  #fibrosis
1
2
314
Winding down for 2022, and am thinking the break over the holidays will be sorely needed, especially as I look to what next year is bringing! Really looking forward to being with the Redx Pharma team in San Francisco for a packed schedule talking exciting…lnkd.in/eh7XTp_Y
1
77
Duncan Young retweeted
Redx are pleased to announce clinical trial collaboration & supply agreement with MSD, for supply of KEYTRUDA® (pembrolizumab), to be used in combination arm of Redx's ongoing Ph 2 clinical study evaluating RXC004 #biliarycancer Read full RNS here: bit.ly/3FAB8Zn
1
4
252
as amazed as I am by what chatGPT can do, I am worried it’s really highlighting how vacuous and cynical the training set of human existence is. 🤣These examples too on point!
Just gonna leave this right here…
2
Duncan Young retweeted
Representatives from Redx had a great time at the Scrip Awards yesterday. We were honoured to be nominated for Biotech of the Year as recognition for the substantial progress we have made so far in all aspects of our pipeline #scripawards #biotech #researchanddevelopment
1
2
Fibrostenosis is a common complication of Crohn’s Disease that isn’t addressed by current therapies. The clever design behind our GI-restricted ROCK inhibitor RXC008 is to allow for potent pharmacological activity without the systemic risk. Exciting to se…lnkd.in/e-qrpV3H
Absolutely! 5 compounds from the Redx team now in clinical development, with more scheduled to follow!
$REDX.L: we know how to make a drug not just a preclinical molecule. Zing! #Jefferies22
2
$REDX.L: we know how to make a drug not just a preclinical molecule. Zing! #Jefferies22
Truly great to see the the pan-RAF molecule JZP815 discovered by Redx Pharma in collaboration with Jazz Pharmaceuticals - 5 projects delivered and active in the clinic is a great testament to small molecule drug discovery expertise in Redx! Excited to exp…lnkd.in/ePAeE4r7
2
I'm happy to share I'm starting a new role as Head of Business Development at Redx Pharma! As we see from recent reports that the majority of breakthrough innovations have their origins outside of large biopharma, I'm looking forward to working with the…lnkd.in/eZSVbcJz
6